A citation-based method for searching scientific literature

Marta Viana-Pereira, Gisele Caravina Almeida, João Norberto Stavale, Susana Malheiro, Carlos Clara, Patrícia Lobo, José Pimentel, Rui Manuel Reis. Pathobiology 2017
Times Cited: 5







List of co-cited articles
23 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
848
80

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
60

TERT promoter mutations in primary and secondary glioblastomas.
Naosuke Nonoguchi, Takashi Ohta, Ji-Eun Oh, Young-Ho Kim, Paul Kleihues, Hiroko Ohgaki. Acta Neuropathol 2013
145
60


Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Marcel Kool, David T W Jones, Natalie Jäger, Paul A Northcott, Trevor J Pugh, Volker Hovestadt, Rosario M Piro, L Adriana Esparza, Shirley L Markant, Marc Remke,[...]. Cancer Cell 2014
409
40

Telomerase: central regulator of all of the hallmarks of cancer.
Kee Chung Low, Vinay Tergaonkar. Trends Biochem Sci 2013
155
40

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
M Labussière, A L Di Stefano, V Gleize, B Boisselier, M Giry, S Mangesius, A Bruno, R Paterra, Y Marie, A Rahimian,[...]. Br J Cancer 2014
101
40

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
40

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
Christian Koelsche, Felix Sahm, David Capper, David Reuss, Dominik Sturm, David T W Jones, Marcel Kool, Paul A Northcott, Benedikt Wiestler, Katja Böhmer,[...]. Acta Neuropathol 2013
186
40

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas.
Yujin Lee, Jaemoon Koh, Seong-Ik Kim, Jae Kyung Won, Chul-Kee Park, Seung Hong Choi, Sung-Hye Park. Acta Neuropathol Commun 2017
37
40

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Rui Batista, Adriana Cruvinel-Carloni, João Vinagre, Joana Peixoto, Telmo A Catarino, Nathalia Cristina Campanella, Weder Menezes, Aline Paixão Becker, Gisele Caravina de Almeida, Marcus M Matsushita,[...]. Int J Cancer 2016
36
40

TERT promoter mutations in telomere biology.
Barbara Heidenreich, Rajiv Kumar. Mutat Res Rev Mutat Res 2017
76
40

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
201
40

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
938
40

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
150
40

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Marc Remke, Vijay Ramaswamy, John Peacock, David J H Shih, Christian Koelsche, Paul A Northcott, Nadia Hill, Florence M G Cavalli, Marcel Kool, Xin Wang,[...]. Acta Neuropathol 2013
99
40

Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Melike Pekmezci, Terri Rice, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Helen Hansen, Hugues Sicotte, Thomas M Kollmeyer, Lucie S McCoy, Gobinda Sarkar,[...]. Acta Neuropathol 2017
146
40

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
156
40

TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.
Janet C Lindsey, Ed C Schwalbe, Sandeep Potluri, Simon Bailey, Daniel Williamson, Steven C Clifford. Acta Neuropathol 2014
35
40

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
40

Adult medulloblastoma: prognostic factors and patterns of relapse.
A W Chan, N J Tarbell, P M Black, D N Louis, M P Frosch, M Ancukiewicz, P Chapman, J S Loeffler. Neurosurgery 2000
132
40

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, Sandro Santagata, Azra Ligon, Heidi Greulich, Rameen Berhoukim, Vladimir Amani, Liliana Goumnerova, Charles G Eberhart,[...]. J Clin Oncol 2011
442
40

Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar,[...]. Acta Neuropathol 2012
974
40



Amplified genes in human gliomas.
V P Collins. Semin Cancer Biol 1993
72
20

Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.
J F Costello, C Plass, W Arap, V M Chapman, W A Held, M S Berger, H J Su Huang, W K Cavenee. Cancer Res 1997
159
20

p14ARF deletion and methylation in genetic pathways to glioblastomas.
M Nakamura, T Watanabe, U Klangby, C Asker, K Wiman, Y Yonekawa, P Kleihues, H Ohgaki. Brain Pathol 2001
174
20

Oncogenes and cancer.
Carlo M Croce. N Engl J Med 2008
579
20

The p53 gene and its role in human brain tumors.
O Bögler, H J Huang, P Kleihues, W K Cavenee. Glia 1995
156
20



Genetic pathways to primary and secondary glioblastoma.
Hiroko Ohgaki, Paul Kleihues. Am J Pathol 2007
874
20

Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.
E Hiyama, K Hiyama, T Yokoyama, T Ichikawa, Y Matsuura. Jpn J Cancer Res 1992
113
20


Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.
T E Taylor, F B Furnari, W K Cavenee. Curr Cancer Drug Targets 2012
145
20

Myc proteins in brain tumor development and maintenance.
Fredrik J Swartling. Ups J Med Sci 2012
25
20


Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies.
Leon Chen, Yuqing Zhang, Jingxuan Yang, John P Hagan, Min Li. Biochim Biophys Acta 2013
51
20

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
M H Ruttledge, J Sarrazin, S Rangaratnam, C M Phelan, E Twist, P Merel, O Delattre, G Thomas, M Nordenskjöld, V P Collins. Nat Genet 1994
429
20


Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites.
Maarten F Bijlsma, Keren S Borensztajn, Henk Roelink, Maikel P Peppelenbosch, C Arnold Spek. Cell Signal 2007
78
20

Copy number alterations of the polycomb gene BMI1 in gliomas.
Valtteri Häyry, Minna Tanner, Tea Blom, Olli Tynninen, Annariikka Roselli, Miina Ollikainen, Hannu Sariola, Kirmo Wartiovaara, Nina N Nupponen. Acta Neuropathol 2008
32
20

Brain tumours: classification and genes.
V P Collins. J Neurol Neurosurg Psychiatry 2004
82
20

BRCA2 is required for neurogenesis and suppression of medulloblastoma.
Pierre-Olivier Frappart, Youngsoo Lee, Jayne Lamont, Peter J McKinnon. EMBO J 2007
76
20

Mutations in SUFU predispose to medulloblastoma.
Michael D Taylor, Ling Liu, Corey Raffel, Chi-chung Hui, Todd G Mainprize, Xiaoyun Zhang, Ron Agatep, Sharon Chiappa, Luzhang Gao, Anja Lowrance,[...]. Nat Genet 2002
556
20

Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas.
Angela J Sievert, Shih-Shan Lang, Katie L Boucher, Peter J Madsen, Erin Slaunwhite, Namrata Choudhari, Meghan Kellet, Phillip B Storm, Adam C Resnick. Proc Natl Acad Sci U S A 2013
160
20

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
G Reifenberger, L Liu, K Ichimura, E E Schmidt, V P Collins. Cancer Res 1993
545
20

Malignant glioma: lessons from genomics, mouse models, and stem cells.
Jian Chen, Renée M McKay, Luis F Parada. Cell 2012
342
20

Genetics of brain tumors.
W A Weiss. Curr Opin Pediatr 2000
18
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.